Number of respondents by (selected*) first cancer site and date of diagnosis: Medicare Advantage

This table provides information about number of CAHPS survey respondents in SEER-CAHPS by selected first cancer sire and time between diagnosis and survey.

First cancer Total number of SEER linked patients First survey before month of first cancer diagnosis First survey within 2 years of first cancer diagnosis First survey within 3–5 years of first cancer diagnosis First survey within 6–10 years of first cancer diagnosis First survey within 11+ years of first cancer diagnosis
N % N % N % N % N %
Prostate 27,613 9,159 33.17 4,317 15.63 4,411 15.97 5,796 20.99 3,930 14.23
Breast 25,168 8,080 32.10 3,342 13.28 3,137 12.46 4,449 17.68 6,160 24.48
Colorectal 15,232 6,933 45.52 1,984 13.03 1,701 11.17 2,133 14.00 2,481 16.29
Lung and Bronchus 12,694 9,824 77.39 1,365 10.75 596 4.70 514 4.05 395 3.11
Melanoma Skin 7,779 3,237 41.61 1,015 13.05 992 12.75 1,162 14.94 1,373 17.65
Bladder 7,077 3,490 49.31 946 13.37 810 11.45 895 12.65 936 13.23
Non-Hodgkins Lymphoma 4,849 2,616 53.95 620 12.79 527 10.87 563 11.61 523 10.79
Uterine Corpus 4,435 1,243 28.03 495 11.16 483 10.89 717 16.17 1,497 33.75
Head/Neck 3,467 1,497 43.18 490 14.13 382 11.02 491 14.16 607 17.51
Kidney/Renal Pelvis 3,287 1,664 50.62 441 13.42 405 12.32 409 12.44 368 11.20
Leukemia 2,759 1,728 62.63 338 12.25 250 9.06 262 9.50 181 6.56
Pancreas 2,351 2,130 90.60 133 5.66 37 1.57 29 1.23 22 0.94
Uterine Cervix 1,942 156 8.03 39 2.01 78 4.02 150 7.72 1,519 78.22
Stomach 1,661 1,123 67.61 213 12.82 90 5.42 115 6.92 120 7.22
Ovary 1,587 795 50.09 180 11.34 123 7.75 154 9.70 335 21.11
Liver/Bile Duct 1,145 952 83.14 104 9.08 49 4.28 29 2.53 11 0.96
Esophagus 815 622 76.32 84 10.31 50 6.13 41 5.03 18 2.21

* Sites reflect most prevalent cancer sites in SEER-CAHPS. Only cancers with sequence number 00 or 01 are included in table.

Last Updated: 16 Oct, 2020